Following a brief pause after the economic crisis, health expenditure is rising again in most OECD countries. Yet, a considerable part of this health expenditure makes little or no contribution to improving people's health. In some cases, it even results in worse health outcomes. Countries could potentially spend significantly less on health care with no impact on health system performance, or on health outcomes. This report systematically reviews strategies put in place by countries to limit ineffective spending and waste. On the clinical front, preventable errors and low-value care are discussed. The operational waste discussion reviews strategies to obtain lower prices for medical goods and to better target the use of expensive inputs. Finally, the report reviews countries experiences in containing administrative costs and integrity violations in health.
The policy study published by the OECD is based on six case studies, an extensive review of the literature, and analysis of relevant data. The report provides context for the analysis of pharmaceutical pricing policies in OECD countries, describes pricing policies employed by the OECD zone and assesses their impact.
The Working Paper sheds light on the extent to which “value” is considered in pricing and/or coverage decisions in 14 OECD member countries. It describes methods used by countries to assess the therapeutic benefits of new products, as well as approaches for economic evaluation, where relevant, and aims to illustrate how value is assessed and what is its impact on pricing and/or reimbursement decisions.
This publication helps policy makers to better understand annuity products and the guarantees they provide in order to optimise the role that these products can play in financing retirement. Product design is a crucial factor in the potential role of annuity products within the pension system, along with the cost and demand for these products, and the resulting risks that are borne by the annuity providers. Increasingly complex products, however, pose additional challenges concerning consumer protection. Consumers need to be aware of their options and have access to unbiased and comprehensible advice and information about these products.
The OECD Pensions Outlook 2016 assesses policy issues regarding strengthening pension systems and, in particular, funded pension plans. It covers defined benefits and defined contribution pension plans; fiscal incentives to save for retirement; policy measures to improve the financial advice for retirement; annuity products and their guarantees; pension design and financial education; and the pension arrangements for public-sector workers, including a comparison with those for private sector workers.
English, PDF, 2,042kb
Access key results from "Health at a Glance Europe 2016" in this chartset.
English, PDF, 766kb
Gli indicatori di stato di salute e qualità dell’assistenza in Italia rimangono fra i migliori in UE. La percentuale di popolazione che riporta esigenze di cure mediche e dentali non soddisfatte è in crescita, in particolare per i gruppi a basso reddito, con un conseguente potenziale aumento delle disuguaglianze nel settore sanitario.
Français, PDF, 1,216kb
Présentation en français sur les résultats clés issus du Panorama de la santé Europe 2016 : "Comment la France se compare".
English, PDF, 674kb
Germany is the EU country that spends the most on health, allocating 11.1% of its GDP to health expenditure in 2015. Recent health spending trends closely follow economic growth, with an annual increase of around 2%.
Français, PDF, 293kb
Les Français jouissent d’une espérance de vie relativement longue par rapport aux autres pays européens, notamment en raison de la bonne qualité des soins délivrée par le système de santé, malgré les contraintes budgétaires.